Protection against Streptococcus pneumoniae invasive pathogenesis by a protein based vaccine is achieved by suppression of nasopharyngeal bacterial density during Influenza A virus co-infection.

Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis (2004) 9.73

Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09

Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev (2006) 5.92

Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA (2007) 3.69

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A (2005) 3.30

Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol (2009) 3.29

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27

The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun (1999) 2.94

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun (2000) 2.84

The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines (2012) 2.79

Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63

Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis (2006) 2.54

T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe (2011) 2.30

Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun (2001) 1.97

Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J (2010) 1.87

Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med (2013) 1.84

Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest (2011) 1.79

Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun (2008) 1.39

The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology (2009) 1.37

Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model. Infect Immun (2009) 1.35

Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J (2013) 1.30

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun (2010) 1.22

Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology (2010) 1.19

Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infect Immun (2015) 1.17

Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog (2013) 1.16

High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis (2014) 1.14

Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine (2012) 1.14

Immune dysfunction and bacterial coinfections following influenza. J Immunol (2013) 1.10

Avian influenza virus isolation and propagation in chicken eggs. Methods Mol Biol (2008) 1.07

Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine (2012) 0.98

Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. MBio (2012) 0.97

CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice. Infect Immun (2013) 0.91

Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci (2008) 0.89

Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells. Am J Respir Crit Care Med (2014) 0.89

Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother (2013) 0.89

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. Vaccine (2014) 0.89

Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model. Vaccine (2014) 0.87

Unbalanced Neonatal CD4(+) T-Cell Immunity. Front Immunol (2014) 0.87

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial. Vaccine (2014) 0.86

TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection. EMBO Rep (2015) 0.85

Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation. Infect Immun (2014) 0.85

Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae. J Vis Exp (2014) 0.81

Challenges in vaccination of neonates, infants and young children. Vaccine (2014) 0.80

The host immune dynamics of pneumococcal colonization: implications for novel vaccine development. Hum Vaccin Immunother (2014) 0.79

Why is coinfection with influenza virus and bacteria so difficult to control? Discov Med (2015) 0.79

An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner. J Infect Dis (2014) 0.78

Understanding the ontogeny of the immune system to promote immune-mediated health for life. Front Immunol (2015) 0.77

Next generation protein based Streptococcus pneumoniae vaccines. Hum Vaccin Immunother (2016) 0.77